Latest Biotech News

Biogen reported Phase 2 success for litifilimab, its anti-BDCA2 antibody program in systemic lupus erythematosus, framing it as a potential pillar within its immunology pipeline. The company said...

Wave Life Sciences’ WVE-007 obesity candidate delivered mixed early clinical data and sent the company’s shares down sharply. In the Phase I INLIGHT trial (NCT06842186), the 240 mg cohort showed...

Kailera Therapeutics outlined plans for an IPO as it advances a Phase 3 obesity drug sourced from Hengrui, positioning the company for entry into a crowded next-generation obesity market dominated...

Insilico Medicine and Eli Lilly agreed to a commercialization deal worth up to $2.75 billion in biobucks, including $115 million upfront, covering certain preclinical AI-discovered oral...

Everlywell and Jona partnered to expand access to Jona’s gut microbiome test through Everlywell’s consumer platform. The collaboration adds microbiome testing inventory to a direct-to-consumer...

Researchers from Zhejiang Cancer Hospital and Peking University identified a stomach cancer biomarker intended to predict which patients are likely to benefit from neoadjuvant immunotherapy. The...

A population-based lung cancer screening study in China reported results suggesting mortality benefit for never-smokers, according to the limited excerpt provided. The work covers a 2017 to 2021...

The University of Maryland Greenebaum Comprehensive Cancer Center received a $3 million award from the National Cancer Institute to expand next-generation cancer research training with a health...

Rocket Pharmaceuticals won FDA approval for Kresladi, a gene therapy for leukocyte-adhesion deficiency type 1 (LAD1), an inherited immunodeficiency that can be fatal in infancy. The company...

Biogen reported positive Phase 2 results for litifilimab, an anti-BDCA2 antibody being developed for lupus. The program showed improvement in skin lesions at 24 weeks, with the company framing the...

Researchers at St. Jude Children’s Research Hospital published findings in Communications Medicine showing that AI methods can identify childhood cancer survivors likely to need additional support...

Zhejiang Cancer Hospital and Peking University researchers identified a stomach cancer biomarker intended to predict which patients are likely to benefit from neoadjuvant immunotherapy. The report...

At ACC, Merck indicated it is leaning toward using a lower Winrevair dose for a pivotal Phase 3 trial in an uncommon form of heart failure. The decision follows a Phase 2 signal described as...

The University of Manchester secured nearly £1 million from UK Research and Innovation (UKRI) to build snail-inspired soft robots for precision drug delivery in bowel cancer. The project aims to...

Casasampere, Carneros, Roda and colleagues published an approach in Nature Communications that extends the small molecule chimera strategy to directly exploit the 26S proteasome for targeted...

Insilico Medicine and Eli Lilly inked a commercialization arrangement tied to Insilico’s AI-discovered preclinical candidates for oral therapeutics. The deal includes an upfront payment of $115...

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center received a $3 million award from the National Cancer Institute for its ARCH K12 Program aimed at training the...

Researchers at the University of Sheffield reported that home testing kits could help close a cervical screening gap for physically disabled women. The study assesses whether home-based pathways...

Merck is adjusting its development path for Winrevair (vericiguat/nearby class reference) in a pivotal Phase 3 trial after Phase 2 results showed its “pretty profound” benefit at the lowest tested...

Biogen reported Phase 2 success for litifilimab in lupus, positioning the anti-BDCA2 antibody as a potential pillar of its immunology pipeline. The company said the therapy improved skin lesions...